Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 65Neoplasms 56Prostatic Neoplasms 44Lung Neoplasms 35Colorectal Neoplasms 35Carcinoma, Non-Small-Cell Lung 24Pancreatic Neoplasms 21Hematologic Neoplasms 19Head and Neck Neoplasms 16Neoplasm Metastasis 15Urinary Bladder Neoplasms 12Ovarian Neoplasms 11Stomach Neoplasms 10Squamous Cell Carcinoma of Head and Neck 10Motor Activity 10Triple Negative Breast Neoplasms 9Multiple Myeloma 9Colonic Neoplasms 9Melanoma 8Glioma 8Anxiety Disorders 8Uterine Cervical Neoplasms 7Hematopoietic and Lymphatic System Neoplasm 7Glioblastoma 7Gastrointestinal Neoplasms 7Esophageal Neoplasms 7Anatomic Stage I Breast Cancer AJCC v8 7Smoking Cessation 6Sarcoma 6Rectal Neoplasms 6

Interventions

Levetiracetam 6perampanel 2Tranexamic Acid 2ziprasidone 1Zolpidem 1Warfarin 1Vigabatrin 1Vecuronium Bromide 1Vancomycin 1Tobramycin 1Standard of Care 1Spironolactone 1Sodium Chloride 1Sevelamer 1Saline Solution 1Rocuronium 1Remifentanil 1Propofol 1Pregabalin 1Piperacillin, Tazobactam Drug Combination 1Pentobarbital 1Oxycodone 1Nifedipine 1Nafcillin 1Molindone 1Methylprednisolone 1Magnesium Sulfate 1Lurasidone Hydrochloride 1Labetalol 1Haloperidol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Seizures × Standard of Care × Clear all
NCT04497142 2024-08-05

Effect of Perampanel on Peritumoral Hyperexcitability in HGG

Dana-Farber Cancer Institute

Phase 1/2 Completed
12 enrolled 8 charts
CNS

Glioma, Seizures

Data powered by HemOnc (CC BY 4.0) Colophon âš¡